Rhizoctonia Solani
Rhizoctonia solani (teleomorph: Thanatephorus cucumeris) is one of common disease throughout the world as well as the most economically important root diseases of cucumber with broad host range that includes most annual and many perennial plants. Generally, Rhizoctonia survives between crops as sclerotia or as
fungal mycelia in the soil. Young plants are more susceptible to
infection than older plants. Application of the fungicides pollutes the environment, leave harmful residues and can lead to the development of resistant strains of the pathogen. Use of nutrients and
micronutrients i.e. pre planting treatment is alternative methods which reduce fungicides usage. OMICS Group International is one of the leading
Open Access Publishers which is publishing 700+ peer-reviewed
journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
High Impact List of Articles
-
Case report of speech language therapy work for voice adequacy of a male transgender
Joaoo Carlos Lopes, Katia Alves Da Silva, Renata Vieira, Viviane Dos Santos Marques, Leslie Piccolotto Ferreira, Marta Assumpcao De Andrada E Silva, Reynaldo Gomes Lopes and Monica Azzariti
Case Report: Clinical Practice
-
Case report of speech language therapy work for voice adequacy of a male transgender
Joaoo Carlos Lopes, Katia Alves Da Silva, Renata Vieira, Viviane Dos Santos Marques, Leslie Piccolotto Ferreira, Marta Assumpcao De Andrada E Silva, Reynaldo Gomes Lopes and Monica Azzariti
Case Report: Clinical Practice
-
Yoga therapy and breast cancer
James M McKivigan*
Review Article: Clinical Practice
-
Yoga therapy and breast cancer
James M McKivigan*
Review Article: Clinical Practice
-
Robotic-assisted minimally invasive surgery and ovarian cancer
Zvi Vaknin and Walter H Gotlieb
Editorial: Clinical Practice
-
Robotic-assisted minimally invasive surgery and ovarian cancer
Zvi Vaknin and Walter H Gotlieb
Editorial: Clinical Practice
-
Zoledronic acid in the management of osteoporosis: the HORIZON trials
E Michael Lewiecki
Clinical Trial Teport: Clinical Practice
-
Zoledronic acid in the management of osteoporosis: the HORIZON trials
E Michael Lewiecki
Clinical Trial Teport: Clinical Practice
-
Zoledronic acid: clinical potential beyond the prevention of skeletal complications in patients with cancer
Adam Brufsky
Drug Evaluation: Clinical Practice
-
Zoledronic acid: clinical potential beyond the prevention of skeletal complications in patients with cancer
Adam Brufsky
Drug Evaluation: Clinical Practice
-
Acknowledgement: Volume 3 Issue 1
Acknowledgements: Clinical Practice
-
Acknowledgement: Volume 3 Issue 1
Acknowledgements: Clinical Practice
Relevant Topics in Clinical